Literature DB >> 18264697

The effect of methylphenidate on auditory information processing in healthy volunteers: a combined EEG/MEG study.

Milena Korostenskaja1, Dubravko Kicić, Seppo Kähkönen.   

Abstract

INTRODUCTION: The psychomotor stimulant methylphenidate (MPH) has been shown to improve attentional processes, reflected in behavioural measures such as vigilance, reaction time and visual attention tasks. The neural mechanisms of MPH action on sensory information processing, however, remain poorly understood. To the authors' knowledge, this present study is the first to investigate whether a single dose of MPH affects neural substrates of passive attention in healthy adults studied with simultaneous whole-head magnetoencephalography (MEG) and electroencephalography (EEG).
METHODS: Monaural left-ear auditory stimuli were presented in an oddball paradigm with infrequent deviant tones differing in frequency and duration. Neuronal activity was recorded with simultaneous whole-head MEG and EEG in 13 healthy subjects (five females; aged 27 +/- 5 years) after oral administration of 40 mg MPH or placebo in a randomised, double-blind, cross-over design. We analysed both electric and magnetic N100, P200 and mismatch negativity (MMN) components.
RESULTS: MPH increased arousal levels in visual analogue scales. MPH had no effect on the dipole strength of MMN or MMNm in either frequency or duration deviations. MPH did, however, reduce P200 amplitudes in EEG.
CONCLUSIONS: The lack of effect of MPH on either MMN or MMNm suggests no association between catecholaminergic activities and MMN generation. However, our findings imply that MPH may change the neural bases of auditory information processing such as the early stimulus evaluation reflected in the P200 component. Dopamine and noradrenaline neurotransmitter systems could be responsible for the modulation of these processes. The exclusive effect of MPH on the P200 component could have a clinical application.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264697     DOI: 10.1007/s00213-007-1065-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  99 in total

Review 1.  Magnetoencephalography (MEG): a non-invasive tool for studying cortical effects in psychopharmacology.

Authors:  Seppo Kähkönen
Journal:  Int J Neuropsychopharmacol       Date:  2005-09-05       Impact factor: 5.176

2.  Neural effects of nicotine during auditory selective attention in smokers: an event-related potential study.

Authors:  Verner Knott; Crystal Blais; Carole Scherling; Jordan Camarda; Anne Millar; Derek Fisher; Judy McIntosh
Journal:  Neuropsychobiology       Date:  2006-04-04       Impact factor: 2.328

3.  The advantage of combining MEG and EEG: comparison to fMRI in focally stimulated visual cortex.

Authors:  Dahlia Sharon; Matti S Hämäläinen; Roger B H Tootell; Eric Halgren; John W Belliveau
Journal:  Neuroimage       Date:  2007-04-19       Impact factor: 6.556

4.  Burst activity of ventral tegmental dopamine neurons is elicited by sensory stimuli in the awake cat.

Authors:  J C Horvitz; T Stewart; B L Jacobs
Journal:  Brain Res       Date:  1997-06-13       Impact factor: 3.252

5.  Effects of methylphenidate on normal children's mood, event-related potentials, and performance in memory scanning and vigilance.

Authors:  L J Peloquin; R Klorman
Journal:  J Abnorm Psychol       Date:  1986-02

Review 6.  The mismatch negativity: a powerful tool for cognitive neuroscience.

Authors:  R Näätänen
Journal:  Ear Hear       Date:  1995-02       Impact factor: 3.570

7.  The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology.

Authors:  Nicholas J Cooper; Hannah Keage; Daniel Hermens; Leanne M Williams; David Debrota; C Richard Clark; Evian Gordon
Journal:  J Integr Neurosci       Date:  2005-03       Impact factor: 2.117

8.  Effects of risperidone on auditory event-related potentials in schizophrenia.

Authors:  Daniel Umbricht; Daniel Javitt; Gerald Novak; John Bates; Simcha Pollack; Jeffrey Lieberman; John Kane
Journal:  Int J Neuropsychopharmacol       Date:  1999-12       Impact factor: 5.176

9.  Enhanced selective attention after low-dose administration of the benzodiazepine antagonist flumazenil.

Authors:  R Smolnik; R Pietrowsky; H L Fehm; J Born
Journal:  J Clin Psychopharmacol       Date:  1998-06       Impact factor: 3.153

10.  Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects.

Authors:  Sumie Leung; Rodney J Croft; Torsten Baldeweg; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2007-07-05       Impact factor: 4.530

View more
  17 in total

Review 1.  How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control.

Authors:  J Leon Kenemans; Seppo Kähkönen
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

Review 2.  Neurophysiological models for new treatment development in schizophrenia: early sensory approaches.

Authors:  Daniel C Javitt
Journal:  Ann N Y Acad Sci       Date:  2015-02-26       Impact factor: 5.691

3.  Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.

Authors:  André Schmidt; Rosilla Bachmann; Michael Kometer; Philipp A Csomor; Klaas E Stephan; Erich Seifritz; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

4.  Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.

Authors:  Patrik Roser; Ida S Haussleiter; Hee-Jeong Chong; Christoph Maier; Wolfram Kawohl; Christine Norra; Georg Juckel
Journal:  Psychopharmacology (Berl)       Date:  2011-05-18       Impact factor: 4.530

Review 5.  Managing Negative Symptoms of Schizophrenia: How Far Have We Come?

Authors:  Joshua T Kantrowitz
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

6.  The effect of single-dose methylphenidate on the rate of error-driven learning in healthy males: a randomized controlled trial.

Authors:  Jonathon R Howlett; He Huang; Cédric M Hysek; Martin P Paulus
Journal:  Psychopharmacology (Berl)       Date:  2017-09-01       Impact factor: 4.530

Review 7.  Cognitive neuroscience of Attention Deficit Hyperactivity Disorder: current status and working hypotheses.

Authors:  Chandan J Vaidya; Melanie Stollstorff
Journal:  Dev Disabil Res Rev       Date:  2008

8.  Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants.

Authors:  Sumie Leung; Rodney J Croft; Valérie Guille; Kirsty Scholes; Barry V O'Neill; K Luan Phan; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2009-12-10       Impact factor: 4.530

9.  MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autism.

Authors:  Timothy P L Roberts; Sarah Y Khan; Mike Rey; Justin F Monroe; Katelyn Cannon; Lisa Blaskey; Sarah Woldoff; Saba Qasmieh; Mike Gandal; Gwen L Schmidt; Deborah M Zarnow; Susan E Levy; J Christopher Edgar
Journal:  Autism Res       Date:  2010-02       Impact factor: 5.216

10.  Can behavioral sensory processing problems guide us to a better pharmacological management of children with attention deficit hyperactivity disorder?: a case report.

Authors:  Ahmad Ghanizadeh
Journal:  Psychiatry (Edgmont)       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.